SMAD3 and malignant colon neoplasm: In summary, we provided evidence that lncRNA MIR570MG augmented in regorafenib-resistant colon cancer cells and conferred resistance by sponging with miR-145, leading to the promotion of Smad3-mediated cell survival, colony formation, and tumor growth.